Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Uterine Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00184093 2017-08-15

Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma

Phase 1/2 Completed

35 enrolled 9 charts

Gynecologic

Uterine Cervical Neoplasms

NCT00006453 2015-12-23

Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy

Phase 3 Completed

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00031954 2015-12-23

Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Phase 2 Completed

105 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00614835 2015-12-22

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Phase NA Completed

25 enrolled

Gynecologic

Uterine Neoplasms

NCT02309658 2015-10-16

Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients

Phase 2 Completed

50 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01652794 2015-08-04

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Phase 1 Completed

12 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Leydig Cell Tumor, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT00267696 2015-04-30

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase 2 Completed

45 enrolled 14 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01196559 2015-02-18

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Phase 2 Completed

44 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00312650 2015-01-12

Doxil and Gemcitabine in Recurrent Ovarian Cancer

Phase 2 Terminated

24 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT00282087 2014-12-01

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

Phase 2 Completed

47 enrolled 16 charts

GynecologicSarcoma

Leiomyosarcoma, Uterine Neoplasms

NCT00388154 2014-11-13

Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer

Phase 2 Completed

21 enrolled 14 charts

Gynecologic

Endometrial Neoplasms

NCT00418093 2014-06-19

Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma

Phase 2 Terminated

19 enrolled 10 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00003449 2014-05-22

Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer

Phase 2 Completed

35 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00183794 2014-05-22

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Phase 2 Completed

20 enrolled 8 charts

Gynecologic

Ovarian Neoplasms, Peritoneal Neoplasms

NCT00014456 2013-08-28

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

35 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Stomach Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT01388621 2013-08-20

PROVE

Phase 2 Unknown

140 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT00583622 2013-05-21

Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients

Phase 2 Terminated

13 enrolled 5 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00004066 2013-03-07

Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma

Phase 2 Completed

82 enrolled

GynecologicSarcoma

Leiomyosarcoma, Ovarian Neoplasms, Sarcoma

NCT00551122 2013-01-23

GemTIP

Phase 1/2 Unknown

23 enrolled

CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms, Central Nervous System Neoplasms, Seminoma, Endodermal Sinus Tumor

NCT00003358 2013-01-16

Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1 Completed

24 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01570582 2012-04-04

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Phase 2 Unknown

314 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00429559 2011-07-22

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

Phase 1/2 Completed

31 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

Clinical Trials

GEMCOL

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

DOVE

EUDARIO

SCENIC

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

ANITA

AddChemo

Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

MITO16MANGO2b

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

PemCiGem

Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma

NItCHE-MITO33

MITO23

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

CLIO

Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer

GCC0319

Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer

MITO27

p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer

PGA

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma

Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy

Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Doxil and Gemcitabine in Recurrent Ovarian Cancer

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer

Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma

Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

PROVE

Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients

Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma

GemTIP

Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma